NCT07155343 Comparison of the Brackets Bonded With Bulk Fill Composite and Conventional Composite in Patients Undergoing Fixed Orthodontic Treatment
| NCT ID | NCT07155343 |
| Status | Recruiting |
| Phase | EARLY_Phase 1 |
| Sponsor | Rizwan Khalil |
| Condition | Survival Rate of Bonded Brackets |
| Study Type | INTERVENTIONAL |
| Enrollment | 53 participants |
| Start Date | 2025-07-21 |
| Primary Completion | 2025-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
Phase 1 is the earliest stage of human testing — safety and dosage are the primary focus. Visits are frequent and medical supervision is intensive. You will be among the first people to receive this treatment.
This trial targets 53 participants in total. It began in 2025-07-21 with a primary completion date of 2025-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The primary objective of this study is to compare the survival rate (days) of orthodontic bracket bond to the tooth, and the secondary objective is to compare the dental plaque accumulation and gingival health using plaque index and gingival index respectively between brackets bonded with bulk fill composite and light cure conventional composite in patients undergoing fixed orthodontic treatment over a period of three months.
Eligibility Criteria
Inclusion Criteria: * • Patients aged between 13 - 40 years * Patients undergoing fixed orthodontic treatment * Patients with good oral hygiene, with grade 1 or below on plaque and gingival indices * All patients who will sign the informed consent/assent form Exclusion Criteria: * • Patients with enamel surface defects * Patients with any periodontal disease i.e. gingivitis or periodontitis * Patients with any systemic diseases i.e. diabetes and hypertension * Pregnant or nursing females * Patients with craniofacial syndromes * Subjects with a previous history of orthodontic or orthopedic treatment
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07155343 clinical trial?
This trial is open to participants of all sexes, aged 13 Years or older, up to 40 Years, studying Survival Rate of Bonded Brackets. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
What phase is the NCT07155343 trial and what does that mean for participants?
Phase 1 trials are the first stage of human testing. The primary goal is to assess safety and determine appropriate dosage levels. Participants are closely monitored. These trials typically involve a small number of volunteers.
Is NCT07155343 currently recruiting?
Yes, NCT07155343 is actively recruiting participants. Contact the research team at rizwan.khalil@aku.edu for enrollment information.
Where is the NCT07155343 trial being conducted?
This trial is being conducted at Karachi, Pakistan.
Who is sponsoring the NCT07155343 clinical trial?
NCT07155343 is sponsored by Rizwan Khalil. The trial plans to enroll 53 participants.